Orphenadrine Citrate
Product Images NDC 33358-274

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 33358-274). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxchange Co., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (4ed1b591 Figure 01)

FDA Label Image

Rxchange Co. (33358-274-60) Orphenadrine Citrate Er, 60 Er Tablets (Rxchange Co. (33358 274 60) Orphenadrine Citrate Er, 60 Er Tablets)

Rxchange Co. (33358-274-60) Orphenadrine Citrate Er, 60 Er Tablets (Rxchange Co. (33358 274 60) Orphenadrine Citrate Er, 60 Er Tablets)
Orphenadrine ER 100mg is a prescription medication available in the form of extended-release tablets, marked with item #0274-60 and NDC code 33358-274-60. This medicine is manufactured by M-Nove Laboratories, located in Somerset, AT. The Lot# and Exp. Date information is not available in the given text. It is a controlled drug that requires a prescription from a licensed healthcare provider. The remaining text appears to be random letters, and it cannot be interpreted as meaningful information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.